Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    _____    _____       ___     __   _      ___    
 /_____//  |  ___|| |  __ \\    / _ \\  | || | ||   / _ \\  
 `____ `   | ||__   | |  \ ||  | / \ || | '--' ||  | / \ || 
 /___//    | ||__   | |__/ ||  | \_/ || | .--. ||  | \_/ || 
 `__ `     |_____|| |_____//    \___//  |_|| |_||   \___//  
 /_//      `-----`   -----`     `---`   `-`  `-`    `---`   
 `-`                                                        
 


Back to frontdoor view